Effect of intracerebroventricular captopril on vasopressin and blood pressure in spontaneously hypertensive rats.
- 1 November 1981
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 3 (6_pt_2)
- https://doi.org/10.1161/01.hyp.3.6_pt_2.ii-71
Abstract
In conscious, unrestrained spontaneously hypertensive rats (SHR), mean arterial blood pressure (MAP) increased from a pretreatment value of 150 +/- 4 to 179 +/- 7mm Hg within 10 min (p less than 0.01) following an intracerebroventricular (i.c.v.) injection of captopril (2 mg/kg body weight), and the plasma vasopressin concentration was increased eightfold (p less than 0.01). MAP than fell to 131 +/- 5 mm Hg at 120 minutes (p less than 0.01), and plasma vasopressin concentration returned to pretreatment levels. The initial increase in MAP was due in large part to increased plasma vasopressin levels since this increase was reduced 50% by pre-treatment with a specific antagonist of the pressor action of vasopressin. The reduction in MAP at 120 minutes in captopril-treated rats may been nonspecific, since a similar effect was observed in SHR given an i.c.v. injection of a control solution. In (Wistar-Kyoto) WKY rats, i.c.v. captopril was without a statistically significant effect on MAP, but the plasma vasopressin concentration increased three-fold (p less than 0.01). These findings may reflect an increased sensitivity of the control system for vasopressin release in the SHR.Keywords
This publication has 13 references indexed in Scilit:
- A new extraction of arginine vasopressin from blood: The use of octadecasilyl-silicaPflügers Archiv - European Journal of Physiology, 1980
- Blood pressure responses of conscious normotensive and spontaneously hypertensive rats to intracerebroventricular and peripheral administration of captopril.Hypertension, 1980
- Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension.Hypertension, 1980
- [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressinJournal of Medicinal Chemistry, 1980
- Studies on the Role of Vasopressin in Blood Pressure Control of Spontaneously Hypertensive Rats with Established Hypertension (SHR, Stroke-Prone Strain)Journal of Cardiovascular Pharmacology, 1979
- The effect of SQ14,225 on systolic blood pressure and urinary excretion of vasopressin in the developing spontaneously hypertensive rat.Hypertension, 1979
- Effects of an Orally Active Converting-Enzyme Inhibitor, SQ 14225, on Pressor Responses to Angiotensin Administered into the Brain Ventricles of Spontaneously Hypertensive RatsClinical Science, 1979
- Vasopressin in the rat with spontaneous hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 1978
- Release of Vasopressin by Angiotensin II1Endocrinology, 1975
- Central mechanisms of the hypertensive action of intraventricular bradykinin in the unanaesthetized ratNeuropharmacology, 1974